Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 8NETWORK 3INDUSTRY 3UNKNOWN 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Esophageal Neoplasms 7Breast Neoplasms 7Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 2Neoplasm Metastasis 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Thymoma 1Thoracic Neoplasms 1Stomach Neoplasms 1Skin Diseases 1Recurrence 1Rectal Neoplasms 1Pain 1Neutropenia 1Neoplasms by Site 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer 1Gastric Adenocarcinoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ductal, Breast 1Carcinoma 1Cancer Pain 1Breast Diseases 1

Interventions

Vinorelbine 1Docetaxel 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × UNKNOWN × Carcinoma, Ductal, Breast × Clear all
NCT01126138 2011-05-04

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

ChineseAMS

Phase 3 Unknown
200 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Carcinoma, Ductal, Breast

Data powered by HemOnc (CC BY 4.0) Colophon âš¡